These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9769950)

  • 21. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
    Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
    Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
    Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The expression and localization of wild-type p53-GFP fused gene on human high-metastasis hepatocellular carcinoma cell line].
    He P; Tang Z; Ye S
    Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):105-7. PubMed ID: 10861118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P53 codon 249 mutation in hepatocellular carcinomas from Nigeria.
    Ndububa DA; Yakicier CM; Ojo OS; Adeodu OO; Rotimi O; Ogunbiyi O; Ozturk M
    Afr J Med Med Sci; 2001; 30(1-2):125-7. PubMed ID: 14510167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases.
    Hosny G; Farahat N; Tayel H; Hainaut P
    Cancer Lett; 2008 Jun; 264(2):201-8. PubMed ID: 18313840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.
    Su H; Zhao J; Xiong Y; Xu T; Zhou F; Yuan Y; Zhang Y; Zhuang SM
    Mutat Res; 2008 May; 641(1-2):27-35. PubMed ID: 18358501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy.
    Gouas D; Shi H; Hainaut P
    Cancer Lett; 2009 Dec; 286(1):29-37. PubMed ID: 19376640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
    Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC
    Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional inactivation but not structural mutation of p53 causes liver cancer.
    Ueda H; Ullrich SJ; Gangemi JD; Kappel CA; Ngo L; Feitelson MA; Jay G
    Nat Genet; 1995 Jan; 9(1):41-7. PubMed ID: 7704023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
    El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
    J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
    Olivier M; Hussain SP; Caron de Fromentel C; Hainaut P; Harris CC
    IARC Sci Publ; 2004; (157):247-70. PubMed ID: 15055300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
    Yakicier MC; Legoix P; Vaury C; Gressin L; Tubacher E; Capron F; Bayer J; Degott C; Balabaud C; Zucman-Rossi J
    Oncogene; 2001 Aug; 20(37):5232-8. PubMed ID: 11526514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hMSH2 genes.
    Yano M; Hamatani K; Eguchi H; Hirai Y; MacPhee DG; Sugino K; Dohi K; Itamoto T; Asahara T
    Eur J Cancer; 2007 Apr; 43(6):1092-100. PubMed ID: 17350822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microsatellite instability and p53 mutations in hepatocellular carcinoma.
    Karachristos A; Liloglou T; Field JK; Deligiorgi E; Kouskouni E; Spandidos DA
    Mol Cell Biol Res Commun; 1999; 2(3):155-61. PubMed ID: 10662591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 249ser p53 mutation in the serum of black southern African patients with hepatocellular carcinoma.
    Kimbi GC; Kew MC; Yu MC; Arakawa K; Hodkinson J
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1185-90. PubMed ID: 16048565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation at codon 249 of p53 gene in a human hepatoblastoma.
    Kar S; Jaffe R; Carr BI
    Hepatology; 1993 Sep; 18(3):566-9. PubMed ID: 8395458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.